Health Care Weekly: Liquidia Drug Marketing for Lung Condition Found to Violate Rival’s Patent After ‘At-Risk’ Launch; CMS Slashes Scope of GLOBE Pricing Model; FDA Seeks Input on Psychedelic Made From Tree Bark; Medline Hospital Bed Recall Tops 1 Million; GAO Report Says Vertical Integration in Pharmacy Saves Patients Money; FTC Presses Hospitals to Post Prices; HHS Seeks to Speed Drug Trials

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • District Court patent ruling threatens commercial status of Liquidia’s pulmonary hypertension drug. • GLOBE model will impact fewer drugmakers, generate far less savings than […]